Share
Other content recommended for you
- A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation?
- Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure
- Comparison of novel oncology drugs that received dual approval from the US accelerated approval and EU conditional marketing authorisation pathways, 2006–2021: a cross-sectional study
- Implantable cardioverter defibrillators: risks accompany the life-saving benefits
- The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?
- Familial risk of atrioventricular block in first-degree relatives
- Quality of evidence behind FDA approvals varies widely
- Cardiac implant registries 2006–2016: a systematic review and summary of global experiences
- Safety of serial MRI in patients with implantable cardioverter defibrillators
- Identifying optimal postmarket surveillance strategies for medical and surgical devices: implications for policy, practice and research